Please provide your email address to receive an email when new articles are posted on . Cannabidiol treatment was associated with median reduction of 67% to 99% in focal aware seizures. All ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Among those deemed “treatment sensitive,” 69.4% ...

A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes for patients who continue to suffer seizures despite being on multiple ...

Los Angeles — Only about 27% of patients newly diagnosed with focal epilepsy are seizure-free on initial anti-seizure medications (ASMs), new research suggested. This is sobering information to pass ...

Temporal lobe epilepsy can trigger intense religious or spiritual experiencesSeizure type and brain area influence mystical ...

Medically reviewed by Nicholas R. Metrus, MD Key Takeaways Stress can cause seizures in people with or without ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. A positive readout of a Rapport Therapeutics seizure medicine in a ...

Most participants with newly diagnosed focal episodes achieve seizure freedom; 27% become seizure-free with first antiseizure medications. HealthDay News — Many people with newly diagnosed focal ...

Longitudinal data suggested that treatment-resistant focal epilepsy may improve over time. Nearly 70% had reduced seizure frequency and some patients achieved seizure freedom. Improvement was not ...